Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectation...

por Boquoi, Amelie, Rings, Veronika, Mohring, Annemarie, Savickaite, Ingrida, Zukovs, Romans, Strapatsas, Judith, Nachtkamp, Kathrin, Kobbe, Guido, Germing, Ulrich, Fenk, Roland
Publicado 2022

18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?

por Zukovs, Romans, Antke, Christina, Mamlins, Eduards, Sawicki, Lino Morris, Mohring, Annemarie, Lopez y Niedenhoff, David, Boquoi, Amelie, Kondakci, Mustafa, Antoch, Gerald, Müller, Hans-Wilhelm, Fenk, Roland, Haas, Rainer
Publicado 2022

Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCI...

por Keitel, Verena, Bode, Johannes Georg, Feldt, Torsten, Walker, Andreas, Müller, Lisa, Kunstein, Anselm, Klindt, Caroline, Killer, Alexander, Senff, Tina, Timm, Jörg, Ostermann, Philipp, Damagnez, Maximilian, Lübke, Nadine, Adams, Ortwin, Schaal, Heiner, Antoch, Gerald, Neubert, Jennifer, Albrecht, Philipp, Meuth, Sven, Elben, Saskia, Mohring, Annemarie, Fischer, Johannes C., Bölke, Edwin, Hoenig, Manfred, Schulz, Ansgar S., Luedde, Tom, Jensen, Björn
Publicado 2021